360 related articles for article (PubMed ID: 23948300)
1. Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically.
Putoczki TL; Thiem S; Loving A; Busuttil RA; Wilson NJ; Ziegler PK; Nguyen PM; Preaudet A; Farid R; Edwards KM; Boglev Y; Luwor RB; Jarnicki A; Horst D; Boussioutas A; Heath JK; Sieber OM; Pleines I; Kile BT; Nash A; Greten FR; McKenzie BS; Ernst M
Cancer Cell; 2013 Aug; 24(2):257-71. PubMed ID: 23948300
[TBL] [Abstract][Full Text] [Related]
2. The interleukin-6 family cytokine interleukin-11 regulates homeostatic epithelial cell turnover and promotes gastric tumor development.
Howlett M; Giraud AS; Lescesen H; Jackson CB; Kalantzis A; Van Driel IR; Robb L; Van der Hoek M; Ernst M; Minamoto T; Boussioutas A; Oshima H; Oshima M; Judd LM
Gastroenterology; 2009 Mar; 136(3):967-77. PubMed ID: 19121317
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130.
Howlett M; Judd LM; Jenkins B; La Gruta NL; Grail D; Ernst M; Giraud AS
Gastroenterology; 2005 Sep; 129(3):1005-18. PubMed ID: 16143138
[TBL] [Abstract][Full Text] [Related]
4. STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice.
Ernst M; Najdovska M; Grail D; Lundgren-May T; Buchert M; Tye H; Matthews VB; Armes J; Bhathal PS; Hughes NR; Marcusson EG; Karras JG; Na S; Sedgwick JD; Hertzog PJ; Jenkins BJ
J Clin Invest; 2008 May; 118(5):1727-38. PubMed ID: 18431520
[TBL] [Abstract][Full Text] [Related]
5. IL-6 and IL-11 as markers for tumor aggressiveness and prognosis in gastric adenocarcinoma patients without mutations in Gp130 subunits.
Necula LG; Chivu-Economescu M; Stanciulescu EL; Bleotu C; Dima SO; Alexiu I; Dumitru A; Constantinescu G; Popescu I; Diaconu CC
J Gastrointestin Liver Dis; 2012 Mar; 21(1):23-9. PubMed ID: 22457856
[TBL] [Abstract][Full Text] [Related]
6. IL-11 signaling as a therapeutic target for cancer.
Putoczki TL; Ernst M
Immunotherapy; 2015; 7(4):441-53. PubMed ID: 25917632
[TBL] [Abstract][Full Text] [Related]
7. IL-11: a prominent pro-tumorigenic member of the IL-6 family.
Grivennikov SI
Cancer Cell; 2013 Aug; 24(2):145-7. PubMed ID: 23948295
[TBL] [Abstract][Full Text] [Related]
8. Cytokine signalling by gp130 regulates gastric mucosal healing after ulceration and, indirectly, antral tumour progression.
Judd LM; Ulaganathan M; Howlett M; Giraud AS
J Pathol; 2009 Mar; 217(4):552-62. PubMed ID: 19097069
[TBL] [Abstract][Full Text] [Related]
9. Repurposing the selective estrogen receptor modulator
Thilakasiri P; Huynh J; Poh AR; Tan CW; Nero TL; Tran K; Parslow AC; Afshar-Sterle S; Baloyan D; Hannan NJ; Buchert M; Scott AM; Griffin MD; Hollande F; Parker MW; Putoczki TL; Ernst M; Chand AL
EMBO Mol Med; 2019 Apr; 11(4):. PubMed ID: 30885958
[TBL] [Abstract][Full Text] [Related]
10. Cytokine signalling via gp130 in gastric cancer.
Howlett M; Menheniott TR; Judd LM; Giraud AS
Biochim Biophys Acta; 2009 Nov; 1793(11):1623-33. PubMed ID: 19665497
[TBL] [Abstract][Full Text] [Related]
11. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis.
Bollrath J; Phesse TJ; von Burstin VA; Putoczki T; Bennecke M; Bateman T; Nebelsiek T; Lundgren-May T; Canli O; Schwitalla S; Matthews V; Schmid RM; Kirchner T; Arkan MC; Ernst M; Greten FR
Cancer Cell; 2009 Feb; 15(2):91-102. PubMed ID: 19185844
[TBL] [Abstract][Full Text] [Related]
12. Stat3: linking inflammation to (gastrointestinal) tumourigenesis.
Ernst M; Putoczki TL
Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):711-8. PubMed ID: 22211709
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathways: IL11 as a tumor-promoting cytokine-translational implications for cancers.
Ernst M; Putoczki TL
Clin Cancer Res; 2014 Nov; 20(22):5579-88. PubMed ID: 25074610
[TBL] [Abstract][Full Text] [Related]
14. Epithelial gp130/Stat3 functions: an intestinal signaling node in health and disease.
Ernst M; Thiem S; Nguyen PM; Eissmann M; Putoczki TL
Semin Immunol; 2014 Feb; 26(1):29-37. PubMed ID: 24434062
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line.
Nakanishi H; Yoshioka K; Joyama S; Araki N; Myoui A; Ishiguro S; Ueda T; Yoshikawa H; Itoh K
Am J Pathol; 2004 Aug; 165(2):471-80. PubMed ID: 15277221
[TBL] [Abstract][Full Text] [Related]
16. STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis.
Judd LM; Bredin K; Kalantzis A; Jenkins BJ; Ernst M; Giraud AS
Gastroenterology; 2006 Oct; 131(4):1073-85. PubMed ID: 17030178
[TBL] [Abstract][Full Text] [Related]
17. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer.
Taniguchi K; Karin M
Semin Immunol; 2014 Feb; 26(1):54-74. PubMed ID: 24552665
[TBL] [Abstract][Full Text] [Related]
18. More than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancer.
Putoczki T; Ernst M
J Leukoc Biol; 2010 Dec; 88(6):1109-17. PubMed ID: 20610798
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 and interleukin-11: same same but different.
Garbers C; Scheller J
Biol Chem; 2013 Sep; 394(9):1145-61. PubMed ID: 23740659
[TBL] [Abstract][Full Text] [Related]
20. IL-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor Microenvironment.
Karakasheva TA; Lin EW; Tang Q; Qiao E; Waldron TJ; Soni M; Klein-Szanto AJ; Sahu V; Basu D; Ohashi S; Baba K; Giaccone ZT; Walker SR; Frank DA; Wileyto EP; Long Q; Dunagin MC; Raj A; Diehl JA; Wong KK; Bass AJ; Rustgi AK
Cancer Res; 2018 Sep; 78(17):4957-4970. PubMed ID: 29976575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
